martedì, 25 gennaio 2022
2 Febbraio 2018

Evaluation of advanced therapy medicines

February 1, 2018 – The European Medicines Agency (EMA) has updated its procedural advice on the evaluation of advanced therapy medicinal products (ATMPs). The update aims to streamline some procedural aspects, strengthen collaboration between EMA’s scientific committees and address specific needs of ATMP developers in the evaluation procedure for initial marketing authorisations, to help developers of these medicines – often small and medium-sized … (leggi tutto)